Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults
Clinical trial NCT07215520 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07215520
- Sponsor
- CastleVax Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-03
- Primary completion
- 2026-09-06
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.